Article
Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program.
AIDS research and human retroviruses - 1 Apr 2008
Lloyd Bradley, O'Connell Robert J, Michael Nelson L, Aviles Ricardo, Palou Elsa, Hernandez Rosalinda, Cooley John, Jagodzinski Linda L
Abstract excerpt
The Honduran Ministry of Health (MOH) HIV antiretroviral treatment program began widespread treatment in 2003. We investigated the prevalence of antiretroviral genotypic resistance in specimens collected and archived from HIV-1-infected antiretroviral-naive patients presenting to initiate treatment between 1 July, 2002 and 30 June, 2003 in San Pedro Sula and Tegucigalpa, Honduras. Of 416 specimens collected, 336...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.